Merck Aktie
WKN DE: A0YD8Q / ISIN: US58933Y1055
06.08.2024 14:11:29
|
Daiichi Sankyo, Merck Expand Partnership To Include Merck's MK-6070
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF.PK) and Merck & Co Inc. (MRK) Tuesday said they have expanded their development and commercialization agreement to include Merck's MK-6070, an investigational T-cell engager targeting delta-like ligand 3 (DLL3), that is expressed at high levels in small cell lung cancer and neuroendocrine tumors.
As per the agreement, Merck will receive an upfront payment of $170 million and has also satisfied a contingent quid obligation from the original collaboration agreement.
The companies will jointly develop and commercialize MK-6070 globally, except in Japan where Merck will maintain exclusive rights. Merck will be solely responsible for manufacturing and supply for MK-6070.
MK-6070 is currently being evaluated in a Phase 1/2 study. The companies plan to evaluate MK-6070 in combination with ifinatamab deruxtecan in certain patients with small cell lung cancer, as well as other potential combinations.
Daiichi Sankyo and Merck had entered into a global partnership in October 2023 to jointly develop and commercialize patritumab deruxtecan, ifinatamab deruxtecan and raludotatug deruxtecan, except in Japan where Daiichi Sankyo would maintain exclusive rights.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck Co.mehr Nachrichten
01.05.25 |
Starker Wochentag in New York: Dow Jones schlussendlich in der Gewinnzone (finanzen.at) | |
01.05.25 |
NYSE-Handel: Dow Jones nachmittags mit Gewinnen (finanzen.at) | |
01.05.25 |
Freundlicher Handel: Dow Jones liegt am Donnerstagmittag im Plus (finanzen.at) | |
01.05.25 |
Gute Stimmung in New York: Dow Jones zum Handelsstart fester (finanzen.at) | |
29.04.25 |
Freundlicher Handel in New York: Dow Jones schlussendlich im Plus (finanzen.at) | |
29.04.25 |
Freundlicher Handel: Dow Jones verbucht am Dienstagnachmittag Zuschläge (finanzen.at) | |
29.04.25 |
NYSE-Handel: Dow Jones in Grün (finanzen.at) | |
29.04.25 |
Dow Jones 30 Industrial-Titel Merck-Aktie: So viel Gewinn hätte ein Investment in Merck von vor 5 Jahren eingebracht (finanzen.at) |
Analysen zu Merck Co.mehr Analysen
Aktien in diesem Artikel
Merck Co. | 73,60 | -1,21% |
|